NCT01061619|Unknown
Pathway to Diagnosis of Ovarian Cancer
MITO-12
Loading search results
MITO-12
Sponsor study identifier
observational
400
3 countries
30
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
The purpose of this study is to describe the prediagnostic symptoms and the events along the pathway to diagnosis of women with ovarian cancer, referred for first-line chemotherapy.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
February 2, 2010
Actual (reported)February 3, 2010
Actual (reported)November 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
November 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
the frequency and duration of symptoms in 12 months preceding ovarian cancer diagnosis
at baseline
time intervals in weeks between prediagnostic sentinel events (onset of persistent symptoms, first physician visit, diagnosis of ovarian cancer)
at baseline
description of prediagnostic patient experiences according to modified Andersen's model of 'total patient delay'
at baseline
Patients with confirmed diagnosis of ovarian cancer, presenting for first-line chemotherapy
UZ Leuven-Gynecological Oncology,
Leuven, Belgium
Charité Universitätsmedizin Berlin Campus Virchow-Klinikum / Frauenklinik
Berlin, Germany
IRCCS Oncologico Bari, Oncologia Medica
Bari, BA, 70126, Italy
Ospedale Riuniti di Bergamo, U.O. di Ostetricia e Ginecologia
Bergamo, BG, 24128, Italy
Ospedale Fatebenefratelli, U.O. di Oncologia
Benevento, BN, 82100, Italy
Azienda Ospedaliera G. Rummo
Benevento, BN, Italy
Università Cattolica del Sacro Cuore, Dipartimento di Oncologia
Campobasso, CB, 86100, Italy
Sandro Pignata, M.D., Ph.D.
National Cancer Institute, Naples
Francesco Perrone, M.D., Ph.D.
National Cancer Institute, Naples
Alessandro Morabito, M.D.,
National Cancer Institute, Naples
Ciro Gallo, M.D., Ph.D.
University of Campania Luigi Vanvitelli
First Submitted
February 2, 2010
First Posted
February 3, 2010
Study Start
January 2010
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 2024
Estimated (date passed)Contact the study team to confirm eligibility.
Azienda Ospedaliera C. Poma
Mantua, MN, 46100, Italy
Azienda Ospedaliera V. Cervello
Palermo, PA, Italy
Ospedale S. Massimo, Day Hospital Oncologico
Penne, PE, 65017, Italy
Centro di Riferimento Oncologico, Divisione di Oncolgia Medica C
Aviano, PN, 33081, Italy
Ospedale S. Chiara
Trento, TN, 38100, Italy
Ospedale S. Bortolo ULSS 6, U.O. di Oncologia Medica
Vicenza, VI, 36100, Italy
Ospedale Mazzoni
Ascoli Piceno, Italy
Policlinico Universitario
Bari, Italy
Universita di Bari Policinico I Clinical Ostetrica e Ginecologica
Bari, Italy
Ospedale Fatebenefratelli
Benevento, Italy
Ospedale Senatore Antonio Perrino
Brindisi, Italy
Universita Cattolica del Sacro Cuore
Campobasso, Italy
Ospedale A. Manzoni
Lecco, Italy
Istituto Nazionale Tumori
Milan, Italy
A.O. Univeristaria Policlinico
Modena, Italy
Azienda Ospedaliera D. Cotugno
Naples, 80131, Italy
Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento Uro-Ginecologico
Naples, 80131, Italy
Università Federico II, Cattedra di Oncologia Medica
Naples, Italy
Ospedale Silvestrini
Perugia, Italy
Ospedale Civile S. Spirito
Pescara, Italy
A.O. S. Maria degli Angeli
Pordenone, Italy
Ospedale S. Giovanni Calibita Fatebenefratelli, UO di Oncologia
Roma, Italy
A.O. di Udine S. Maria della Misericordia
Udine, Italy
Jane Bryce, MSN
National Cancer Institute, Naples
Marzia Falanga, BSN
S. Giuseppe Moscati Hospital, Avellino
Carmen Pisano, MD
National Cancer Institute, Naples
Marilina Piccirillo, MD
National Cancer Institute, Naples
Massimo Di Maio, M.D.
National Cancer Institute, Naples
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 2024
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
March 24, 2023
Record last verified: 2023-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: